Bryostatin 1-tamoxifen combinations show synergistic effects on the inhibition of growth of P388 cells in vitro

A. T. McGown, G. Jayson, George Pettit, M. S. Haran, T. H. Ward, D. Crowther

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

This study shows that combinations of bryostatin 1, a novel modulator of protein kinase C currently under clinical evaluation, with the anti-oestrogenic agent tamoxifen caused a large synergistic enhancement of growth inhibition in P388 cells in vitro. The growth-inhibitory effects of bryostatin 1 in the presence of non-inhibitory concentrations of tamoxifen were increased by approximately 200-fold, whereas growth inhibition by tamoxifen in the presence of non-inhibitory concentrations of bryostatin 1 were increased over 30-fold. These data have been confirmed by isobologram analysis. The precise mechanism underlying this effect is unknown, although preliminary data implicating protein kinase C is presented. The magnitude of this synergistic effect, together with evidence of clinical responses seen when these agents were given sequentially in ovarian cancer, merits further study.

Original languageEnglish (US)
Pages (from-to)216-220
Number of pages5
JournalBritish Journal of Cancer
Volume77
Issue number2
StatePublished - 1998

Fingerprint

Tamoxifen
Protein Kinase C
Growth
Ovarian Neoplasms
bryostatin 1
In Vitro Techniques

Keywords

  • Bryostatin
  • Protein kinase C
  • Synergy
  • Tamoxifen

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Bryostatin 1-tamoxifen combinations show synergistic effects on the inhibition of growth of P388 cells in vitro. / McGown, A. T.; Jayson, G.; Pettit, George; Haran, M. S.; Ward, T. H.; Crowther, D.

In: British Journal of Cancer, Vol. 77, No. 2, 1998, p. 216-220.

Research output: Contribution to journalArticle

McGown, A. T. ; Jayson, G. ; Pettit, George ; Haran, M. S. ; Ward, T. H. ; Crowther, D. / Bryostatin 1-tamoxifen combinations show synergistic effects on the inhibition of growth of P388 cells in vitro. In: British Journal of Cancer. 1998 ; Vol. 77, No. 2. pp. 216-220.
@article{abeb6b9751134ea291d125518718c3da,
title = "Bryostatin 1-tamoxifen combinations show synergistic effects on the inhibition of growth of P388 cells in vitro",
abstract = "This study shows that combinations of bryostatin 1, a novel modulator of protein kinase C currently under clinical evaluation, with the anti-oestrogenic agent tamoxifen caused a large synergistic enhancement of growth inhibition in P388 cells in vitro. The growth-inhibitory effects of bryostatin 1 in the presence of non-inhibitory concentrations of tamoxifen were increased by approximately 200-fold, whereas growth inhibition by tamoxifen in the presence of non-inhibitory concentrations of bryostatin 1 were increased over 30-fold. These data have been confirmed by isobologram analysis. The precise mechanism underlying this effect is unknown, although preliminary data implicating protein kinase C is presented. The magnitude of this synergistic effect, together with evidence of clinical responses seen when these agents were given sequentially in ovarian cancer, merits further study.",
keywords = "Bryostatin, Protein kinase C, Synergy, Tamoxifen",
author = "McGown, {A. T.} and G. Jayson and George Pettit and Haran, {M. S.} and Ward, {T. H.} and D. Crowther",
year = "1998",
language = "English (US)",
volume = "77",
pages = "216--220",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Bryostatin 1-tamoxifen combinations show synergistic effects on the inhibition of growth of P388 cells in vitro

AU - McGown, A. T.

AU - Jayson, G.

AU - Pettit, George

AU - Haran, M. S.

AU - Ward, T. H.

AU - Crowther, D.

PY - 1998

Y1 - 1998

N2 - This study shows that combinations of bryostatin 1, a novel modulator of protein kinase C currently under clinical evaluation, with the anti-oestrogenic agent tamoxifen caused a large synergistic enhancement of growth inhibition in P388 cells in vitro. The growth-inhibitory effects of bryostatin 1 in the presence of non-inhibitory concentrations of tamoxifen were increased by approximately 200-fold, whereas growth inhibition by tamoxifen in the presence of non-inhibitory concentrations of bryostatin 1 were increased over 30-fold. These data have been confirmed by isobologram analysis. The precise mechanism underlying this effect is unknown, although preliminary data implicating protein kinase C is presented. The magnitude of this synergistic effect, together with evidence of clinical responses seen when these agents were given sequentially in ovarian cancer, merits further study.

AB - This study shows that combinations of bryostatin 1, a novel modulator of protein kinase C currently under clinical evaluation, with the anti-oestrogenic agent tamoxifen caused a large synergistic enhancement of growth inhibition in P388 cells in vitro. The growth-inhibitory effects of bryostatin 1 in the presence of non-inhibitory concentrations of tamoxifen were increased by approximately 200-fold, whereas growth inhibition by tamoxifen in the presence of non-inhibitory concentrations of bryostatin 1 were increased over 30-fold. These data have been confirmed by isobologram analysis. The precise mechanism underlying this effect is unknown, although preliminary data implicating protein kinase C is presented. The magnitude of this synergistic effect, together with evidence of clinical responses seen when these agents were given sequentially in ovarian cancer, merits further study.

KW - Bryostatin

KW - Protein kinase C

KW - Synergy

KW - Tamoxifen

UR - http://www.scopus.com/inward/record.url?scp=0031965131&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031965131&partnerID=8YFLogxK

M3 - Article

C2 - 9460991

AN - SCOPUS:0031965131

VL - 77

SP - 216

EP - 220

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 2

ER -